glp-1 and crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential GLP-1 Medications: Reimagining the Treatment

Diabetes leads to a significantly accelerated incidence of various related macrovascular complications, including peripheral vascular disease and cardiovascular disease (the most common cause of mortality in diabetes), as well as microvascular complications such as kidney disease and retinopathy

Carolyn Dean MD ND.

Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon

The GLP-1 Exit Strategy: Evidence-Based Methods to Keep the Weight Off After Stopping Ozempic, Wegovy, and Mounjaro

A balanced digestive system aids nutrient absorption and helps regulate appetite signals

GLP-1 Patch does not contain synthetic GLP-1 and is not a GLP-1 agonist drug